Ross C. Walker, who also is an adjunct assistant professor in UC San Diego's Department of Chemistry and Biochemistry as well as an NVIDIA CUDA Fellow, was recognized for his work on acceleration of molecular dynamics simulations using graphics processing units (GPUs). Ross C. Walker's work, released as part of the AMBER software, a widely used package of molecular simulation programs is transforming the way in which hundreds of computational scientists approach their simulation work bringing supercomputer performance to the desktop. Ross C. Walker was presented with the award on March 29, 2011 at the American Chemical Society's National Meeting in Anaheim, California.
"We are proud of Ross' scientific and technical achievements in computational chemistry, especially his outstanding recent work porting AMBER kernels to GPUs", stated Michael Norman, SDSC's director. "This recognition by HP/ACM is well deserved."
Ross C. Walker, a native of the United Kingdom, joined SDSC in March 2006, after working at The Scripps Research Institute as a research associate in the lab of David Case. Ross C. Walker's current research is in the area of developing new molecular dynamics algorithms. Specifically, Ross C. Walker and his team are studying protein reactivity and reaction pathways, with the goal of furthering the understanding of such complex processes in order to aid the development of new drugs for treatment of various diseases such as influenza, and to improve current biofuel technologies.
"One of the biggest problems facing scientists running simulations of systems of biological interest is the difficulties faced in obtaining access to supercomputers for extended periods of time", stated Ross C. Walker. "GPUs offer the potential for supercomputing performance on the average desktop, giving researchers the ability to test multiple hypotheses in real time. The work we are doing in the Walker Molecular Dynamics Lab at SDSC to develop GPU accelerated software promises to transform the way in which scientists approach applying molecular dynamics techniques to the understanding of enzymatic pathways, and ultimately the design of new drugs and biological catalysts."